Cargando…

Oesophageal adenocarcinoma: In the era of extended lymphadenectomy, is the value of neoadjuvant therapy being attenuated?

BACKGROUND: Neoadjuvant chemotherapy (NACT) and oesophagectomy is the standard of care for resectable oesophageal adenocarcinomas. Survival outcomes following resection have been improving over time while NACT remain largely unchanged. Indeed, a recent meta-analysis of randomized control trials did...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jin-Soo, Van der Wall, Hans, Kennedy, Catherine, Falk, Gregory L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554721/ https://www.ncbi.nlm.nih.gov/pubmed/34754391 http://dx.doi.org/10.4240/wjgs.v13.i10.1235

Ejemplares similares

Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours
por: Thomaschewski, Michael, et al.
Publicado: (2018)

Clinical value of extended lymphadenectomy in radical surgery for pancreatic head carcinoma at different T stages
por: Lyu, Shao-Cheng, et al.
Publicado: (2022)

Extended Lymphadenectomy for Gastric Cancer in the Neoadjuvant Era: Current Status, Clinical Implications and Contentious Issues
por: Marano, Luigi, et al.
Publicado: (2023)

Neoadjuvant therapy in relation to lymphadenectomy and resection margins during surgery for oesophageal cancer
por: Kauppila, Joonas H., et al.
Publicado: (2018)

Bowel function and quality of life after minimally invasive colectomy with D3 lymphadenectomy for right-sided colon adenocarcinoma
por: Lee, Ki-Myung, et al.
Publicado: (2020)

D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy
por: Shrikhande, Shailesh V, et al.
Publicado: (2013)

Predicting Response to Neoadjuvant Therapy in Oesophageal Adenocarcinoma
por: Jiang, William, et al.
Publicado: (2022)

Patterns of recurrence in oesophageal cancer following oesophagectomy in the era of neoadjuvant chemotherapy
por: Knight, W. R. C., et al.
Publicado: (2018)

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
por: Petrillo, A., et al.
Publicado: (2022)

Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?
por: Reggiani Bonetti, Luca, et al.
Publicado: (2017)

Unnecessity of lymph node regression evaluation for predicting gastric adenocarcinoma outcome after neoadjuvant chemotherapy
por: Zhu, Yue-Lu, et al.
Publicado: (2019)

Prognostic implications of the extent of downstaging after neoadjuvant therapy for oesophageal adenocarcinoma and oesophageal squamous cell carcinoma
por: Kamarajah, Sivesh K, et al.
Publicado: (2023)

Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience
por: Graham, David, et al.
Publicado: (2018)

Lymphadenectomy and risk of reoperation or mortality shortly after surgery for oesophageal cancer
por: Lagergren, Jesper, et al.
Publicado: (2016)

Extent and consequences of lymphadenectomy in oesophageal cancer surgery: case vignette survey
por: de Gouw, Didi JJM, et al.
Publicado: (2020)

Comparing extended and standard lymphadenectomy surgeries for bladder cancer (complications, final outcomes and effects of neoadjuvant chemotherapy)
por: Thiara, GS, et al.
Publicado: (2015)

Efficacy and safety of laparoscopic radical resection following neoadjuvant therapy for pancreatic ductal adenocarcinoma: A retrospective study
por: He, Yong-Gang, et al.
Publicado: (2022)

Benchmarking of a Simple Scintigraphic Test for Gastro-oesophageal Reflux Disease That Assesses Oesophageal Disease and Its Pulmonary Complications
por: Burton, Leticia, et al.
Publicado: (2018)

Added value of systemic inflammation markers for monitoring response to neoadjuvant chemotherapy in breast cancer patients
por: Ke, Zi-Rui, et al.
Publicado: (2022)

Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis
por: Lee, Jung Il, et al.
Publicado: (2019)

Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients
por: El Mashed, Shereen, et al.
Publicado: (2022)

Dose-escalated neoadjuvant chemoradiotherapy for locally advanced oesophageal or oesophagogastric junctional adenocarcinoma
por: Duque-Santana, Victor, et al.
Publicado: (2022)

Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy
por: M. Naeini, Marjan, et al.
Publicado: (2023)

Predictive value of indirect bilirubin before neoadjuvant chemoradiotherapy in evaluating prognosis of local advanced rectal cancer patients
por: Li, Shuo-Feng, et al.
Publicado: (2022)

AB045. Extended lymphadenectomy versus non-extended lymphadenectomy in radical cystectomy for bladder cancer: a meta-analysis
por: Yan, Binyuan
Publicado: (2016)

Novel technique for lymphadenectomy along left recurrent laryngeal nerve during thoracoscopic esophagectomy
por: Chen, Wen-Shu, et al.
Publicado: (2020)

Extended lymphadenectomy in hilar cholangiocarcinoma: What it will bring?
por: Li, Jian, et al.
Publicado: (2020)

Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy
por: Liu, Zi-Ning, et al.
Publicado: (2021)

Predictive value of a serum tumor biomarkers scoring system for clinical stage II/III rectal cancer with neoadjuvant chemoradiotherapy
por: Zhao, Jie-Yi, et al.
Publicado: (2022)

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy
por: Powell, A. G. M. T., et al.
Publicado: (2020)

Neutrophil to lymphocyte ratio as a predictor of response to neoadjuvant chemotherapy and survival in oesophageal adenocarcinoma
por: Powell, A. G. M. T., et al.
Publicado: (2020)

Shrinkage versus fragmentation response in neoadjuvantly treated oesophageal adenocarcinoma: significant prognostic relevance
por: Graham Martinez, Cristina, et al.
Publicado: (2022)

Postoperative mortality and morbidity after D2 lymphadenectomy for gastric cancer: A retrospective cohort study
por: Brisinda, Giuseppe, et al.
Publicado: (2022)

Retrospective review of total neoadjuvant therapy
por: Babar, Laila, et al.
Publicado: (2019)

The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction
por: Curtis, Nathan J, et al.
Publicado: (2014)

Extended lymphadenectomy for locally advanced and recurrent rectal cancer
por: Georgiou, Panagiotis A., et al.
Publicado: (2017)

Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas
por: Cox, Samantha J., et al.
Publicado: (2017)

Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection
por: Zhang, Li-Peng, et al.
Publicado: (2020)

Prognostic value of claudin 18.2 expression in gastric adenocarcinoma
por: Kayikcioglu, Erkan, et al.
Publicado: (2023)

The Value of Paratracheal Lymphadenectomy in Esophagectomy for Adenocarcinoma of the Esophagus or Gastroesophageal Junction: A Systematic Review of the Literature
por: Gantxegi, Amaia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_08r41anjmji4b99fjf4m8f78en